MedTrace Logo

Characterize Tumor Hypoxia by Magnetic Resonance Imaging

NCT03987568 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-12-21

No results posted yet for this study

Summary

The purpose of this research study is to measure the hypoxia (low oxygen condition) in prostate cancers and its effect in survival. In this study, investigators will assess hypoxia by magnetic resonance imaging (MRI) and create a hypoxia score. Investigators will study the hypoxia score and how it correlates (if any) to the disease aggressiveness as well as its effect on the treatment outcomes.

Conditions

Interventions

OTHER

Blood draws

Blood draws at two specified timepoints - the first is during the MRI and the second is scheduled during participant's prostatectomy.

DIAGNOSTIC_TEST

Magnetic resonance imaging (MRI)

At the beginning of study magnetic resonance imaging MRI will be completed.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Gagan Deep, Ph.D · Wake Forest University Health Sciences

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-10
Primary Completion
2021-11-15
Completion
2021-11-15
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03987568 on ClinicalTrials.gov